• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . VCL/ICAM-1 pathway is associated with lung inflammatory damage in SARS-CoV-2 Omicron infection

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Apr 23;16(1):3801.
doi: 10.1038/s41467-025-59145-y. VCL/ICAM-1 pathway is associated with lung inflammatory damage in SARS-CoV-2 Omicron infection

Mingshan Xue[SUP] #[/SUP][SUP] 1 2 3 4 [/SUP], Zhiwei Lin[SUP] #[/SUP][SUP] 1 2 [/SUP], Youli Wen[SUP] #[/SUP][SUP] 5 [/SUP], Shaohui Fan[SUP] 6 [/SUP], Youxia Li[SUP] 6 [/SUP], Hui-Qi Qu[SUP] 7 [/SUP], Qiurong Hu[SUP] 1 [/SUP], Qian Guo[SUP] 1 [/SUP], Lijun Su[SUP] 1 [/SUP], Qianyue Yang[SUP] 1 [/SUP], Jiahong Chen[SUP] 1 [/SUP], Chuci Jiang[SUP] 1 [/SUP], Huimin Huang[SUP] 1 [/SUP], Peiyan Zheng[SUP] 1 [/SUP], Ning Li[SUP] 1 [/SUP], Quan Yuan[SUP] 5 [/SUP], Meixia Zhang[SUP] 5 [/SUP], Xin Zhao[SUP] 5 [/SUP], Qunhua Wu[SUP] 5 [/SUP], Fengyu Hu[SUP] 3 [/SUP], Lu Li[SUP] 3 [/SUP], Xiaowen Wang[SUP] 6 [/SUP], Peixin Liu[SUP] 8 [/SUP], Hakon Hakonarson[SUP] 7 9 10 [/SUP], Zhiping Deng[SUP] 5 [/SUP], Hongman Wang[SUP] 6 [/SUP], Xiaoping Tang[SUP] 1 3 4 [/SUP], Baoqing Sun[SUP] 11 12 13 [/SUP]



Affiliations
Free article Abstract

SARS-CoV-2 variants present diverse clinical manifestations, necessitating deeper insights into their pathogenic effects. This study employs multi-omics approaches to investigate the molecular mechanisms underlying SARS-CoV-2 infection, focusing on vascular damage. Plasma proteomic analysis of unvaccinated participants infected with Omicron BA.2.76 or ancestral variants identifies key signaling pathways associated with endothelial dysfunction, with the vinculin (VCL) pathway emerging as a hallmark of Omicron infections, contributing to lung exudation. Metabolomic analysis of plasma samples from the same cohort reveals disruptions in immune function, cell membrane integrity, and metabolic processes, including altered tricarboxylic acid cycle and glycolysis pathways. An integrated analysis of proteomic and metabolomic data underscores the role of VCL in inflammation and extravasation, highlighting its interactions with adhesion molecules and inflammatory metabolites. A validation cohort of plasma samples from Omicron-infected participants confirms this association by replicating proteomic analysis, showing elevated VCL levels correlated with inflammatory markers. Functional studies in a male rat model of lung injury demonstrate that anti-VCL intervention reduces plasma VCL levels, mitigates alveolar edema, and restores alveolar-capillary barrier integrity, as assessed by histological staining and electron microscopy, thereby illustrating VCL modulation's impact on vascular leakage and extravasation. These findings establish VCL as a potential therapeutic target for mitigating vascular complications in SARS-CoV-2 infections.


 
Back
Top Bottom